Ir para o conteúdo principal

Infelizmente, não oferecemos suporte total ao seu navegador. Se for possível, atualize para uma versão mais recente ou use o Mozilla Firefox, o Microsoft Edge, o Google Chrome ou o Safari 14 ou mais recente. Se não conseguir e precisar de suporte, envie seu feedback.

Gostaríamos de receber seu feedback sobre essa nova experiência.Diga-nos sua opiniãoabre em uma nova guia/janela

Elsevier
Publique conosco

Sponsors & Exhibitors

Commercial opportunities

Choose from a variety of sponsorship and commercial options to raise your profile and position your company as a thought leader in the community.

Download sales packabre em uma nova guia/janela

Reasons why being a sponsor is a brilliant marketing strategy

  • Highly targeted marketing – reach your community

  • Brand awareness & recognition – logo and advertisement placement

  • Access to knowledge – find out about new research being undertaken

  • Engage with your audience online

  • Media exposure - benefit from being promoted throughout Elsevier’s marketing process

  • Enhance credibility – highlight your company’s expertise to a captive audience

  • Generate new sales & form new partnerships – with registrants, vendors and speakers

  • Leveraged lead generation - the chance to be recommended to attendees’ connections

To discuss your requirements or to book sponsorship or exhibit space please contact:

Chloe Partridge Conference Sponsorship & Classified Advertising Sales Executive Tel: +44 (0) 1865 843 346 Email: [email protected]abre em uma nova guia/janela

Please do not email credit card information under any circumstances

Sponsor

Pharmaron

Pharmaron’s Clinical Pharmacology Center provides full-service early-phase clinical research for investigational products, delivering clinical studies with the best quality, cost, and timelines available in the industry. Our 96-bed facility in Baltimore, US, is a recognised viral and bacterial challenge study site, with an experienced team and facility design providing operational excellence to ensure precision and integrity for all studies. Our expertise in First-In-Human studies in multiple therapeutic areas, especially in infectious disease and vaccines, combined with our full suite of clinical pharmacology services, allows our team to advance drug development programs rapidly. Pharmaron has completed >50 viral/bacterial vaccine or challenge studies in campylobacter, cryptosporidium, cholera, influenza, CMV, streptococcus, staphylococcus, RSV, SARS-CoV-2 and norovirus.

https://www.pharmaron.com/abre em uma nova guia/janela

Pharmaron

Exhibitors

JPT Peptide Technologies

We are the Peptide Experts!

For over 20 years, JPT Peptide Technologies has been at the cutting edge of peptide synthesis, pioneering patented technologies in the fields of peptide libraries, pools and microarrays as well as micro-scale synthesis.

Our peptide synthesis service ranges from micro-scale synthesis (10 - 50 nmol) to intermediate peptide synthesis (1 – 100 mg) with high throughput capacities for tens of thousands of peptides per month. Select your peptide format (pool, library, ELISA, microarray, etc.), peptide purity (from crude up to >98%), and optional modifications (phospho, biotin, dyes and labels, (macro)cyclization, conjugation, stable-isotope labeling, etc.).

Our state-of-the-art laboratories are located in Berlin, Germany and JPT operates according to the latest ISO 9001:2015 regulations.

www.jpt.comabre em uma nova guia/janela

JPT Peptide Technologies

Ovagen

Ovagen is a biotechnology company that has developed a proprietary process of producing the world’s first Germ-Free chicken eggs for use in vaccine manufacture, research & development, and other biopharmaceutical applications. Germ-free eggs transform vaccine production by:

  • Eliminating bacterial contamination and reducing antimicrobial resistance, a holy grail for vaccines

  • Increasing the yield of vaccines per egg

  • Increasing quality, security, and sustainability

  • Reducing carbon footprint, and

  • Allowing more efficient and cost-effective production of vaccines therefore improving access by poorer nations.

https://ovagen.ie/abre em uma nova guia/janela

Ovagen